Mary Petrofsky

1.7k total citations
37 papers, 1.4k citations indexed

About

Mary Petrofsky is a scholar working on Epidemiology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Mary Petrofsky has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 30 papers in Infectious Diseases and 7 papers in Organic Chemistry. Recurrent topics in Mary Petrofsky's work include Mycobacterium research and diagnosis (36 papers), Tuberculosis Research and Epidemiology (28 papers) and Quinazolinone synthesis and applications (7 papers). Mary Petrofsky is often cited by papers focused on Mycobacterium research and diagnosis (36 papers), Tuberculosis Research and Epidemiology (28 papers) and Quinazolinone synthesis and applications (7 papers). Mary Petrofsky collaborates with scholars based in United States, Vietnam and Tunisia. Mary Petrofsky's co-authors include Luiz E. Bermudez, Peter Kolonoski, Lawrence S. Young, Martin Wu, Félix J. Sangari, Joseph R. Goodman, Lowell S. Young, Yongjun Li, Clark B. Inderlied and Lia Danelishvili and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Mary Petrofsky

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Petrofsky United States	24	1.0k	859	294	244	166	37	1.4k
Peter Kolonoski United States	19	831 0.8×	722 0.8×	167 0.6×	186 0.8×	147 0.9×	27	1.1k
Thomas F. Byrd United States	22	1.3k 1.2×	1.1k 1.3×	287 1.0×	411 1.7×	203 1.2×	38	2.0k
Lia Danelishvili United States	22	938 0.9×	747 0.9×	203 0.7×	404 1.7×	116 0.7×	54	1.3k
Matt D. Johansen Australia	19	799 0.8×	637 0.7×	171 0.6×	280 1.1×	88 0.5×	44	1.2k
Andrés Obregón‐Henao United States	21	543 0.5×	763 0.9×	285 1.0×	299 1.2×	196 1.2×	45	1.2k
J. Bennedsen Denmark	16	868 0.8×	941 1.1×	326 1.1×	290 1.2×	211 1.3×	41	1.4k
B Rivoire United States	18	702 0.7×	741 0.9×	240 0.8×	283 1.2×	173 1.0×	28	1.3k
Tridia van der Laan Netherlands	13	955 0.9×	1.1k 1.2×	313 1.1×	245 1.0×	220 1.3×	15	1.4k
Audrey Bernut France	22	1.2k 1.2×	962 1.1×	267 0.9×	246 1.0×	105 0.6×	30	1.6k
Werner B. Schaefer United States	23	1.1k 1.1×	839 1.0×	128 0.4×	279 1.1×	184 1.1×	48	1.5k

Countries citing papers authored by Mary Petrofsky

Since Specialization

Citations

This map shows the geographic impact of Mary Petrofsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Petrofsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Petrofsky more than expected).

Fields of papers citing papers by Mary Petrofsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Petrofsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Petrofsky. The network helps show where Mary Petrofsky may publish in the future.

Co-authorship network of co-authors of Mary Petrofsky

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Petrofsky. A scholar is included among the top collaborators of Mary Petrofsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Petrofsky. Mary Petrofsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reyes, Kevin, et al.. (2024). Shared decision-making needs, barriers, and facilitators of patients with newly diagnosed advanced cancer in the hospital: a multi-level, mixed-methods study. Supportive Care in Cancer. 32(5). 315–315. 2 indexed citations

Bermudez, Luiz E., et al.. (2010). Peyer's Patch-Deficient Mice Demonstrate ThatMycobacterium aviumsubsp.paratuberculosisTranslocates across the Mucosal Barrier via both M Cells and Enterocytes but Has Inefficient Dissemination. Infection and Immunity. 78(8). 3570–3577. 55 indexed citations

Yamazaki, Yoshitaka, Lia Danelishvili, Martin Wu, et al.. (2005). The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells. Cellular Microbiology. 8(5). 806–814. 94 indexed citations

Bermudez, Luiz E., Mary Petrofsky, & Félix J. Sangari. (2004). Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis‐like mechanism and survives in a compartment that differs from that with extracellular phenotype. Cell Biology International. 28(5). 411–419. 17 indexed citations

Li, Yongjun, et al.. (2004). A Mycobacterium avium PPE gene is associated with the ability of the bacterium to grow in macrophages and virulence in mice. Cellular Microbiology. 7(4). 539–548. 101 indexed citations

Bermudez, Luiz E., Peter Kolonoski, Mary Petrofsky, et al.. (2004). SRI-286, a Thiosemicarbazole, in Combination with Mefloquine and Moxifloxacin for Treatment of Murine Mycobacterium avium Complex Disease. Antimicrobial Agents and Chemotherapy. 48(9). 3556–3558. 35 indexed citations

Bermudez, Luiz E., Peter Kolonoski, Mary Petrofsky, et al.. (2003). Mefloquine, Moxifloxacin, and Ethambutol Are a Triple‐Drug Alternative to Macrolide‐Containing Regimens for Treatment ofMycobacterium aviumDisease. The Journal of Infectious Diseases. 187(12). 1977–1980. 38 indexed citations

Li, Yongjun, Mary Petrofsky, & Luiz E. Bermudez. (2002). Mycobacterium tuberculosisUptake by Recipient Host Macrophages Is Influenced by Environmental Conditions in the Granuloma of the Infectious Individual and Is Associated with Impaired Production of Interleukin-12 and Tumor Necrosis Factor Alpha. Infection and Immunity. 70(11). 6223–6230. 23 indexed citations

Wagner, Dirk, Félix J. Sangari, Sang Kim, Mary Petrofsky, & Luiz E. Bermudez. (2002). Mycobacterium aviuminfection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo. Journal of Leukocyte Biology. 71(1). 80–88. 32 indexed citations

10.

Sangari, Félix J., Joseph R. Goodman, Mary Petrofsky, Peter Kolonoski, & Luiz E. Bermudez. (2001). Mycobacterium avium Invades the Intestinal Mucosa Primarily by Interacting with Enterocytes. Infection and Immunity. 69(3). 1515–1520. 54 indexed citations

11.

Mukherjee, Sandeep, et al.. (2001). The White Morphotype ofMycobacterium avium‐intracellulareIs Common in Infected Humans and Virulent in Infection Models. The Journal of Infectious Diseases. 184(11). 1480–1484. 14 indexed citations

12.

Petrofsky, Mary, et al.. (1999). Neutrophils fromMycobacterium avium-Infected Mice Produce TNF-α, IL-12, and IL-1β and Have a Putative Role in Early Host Response. Clinical Immunology. 91(3). 354–358. 75 indexed citations

13.

Bermudez, Luiz E., Mary Petrofsky, & Paul Stevens. (1998). Treatment with recombinant granulocyte colony‐stimulating factor (Filgrastin^TM) stimulates neutrophils and tissue macrophages and induces an effective non‐specific response against Mycobacterium avium in mice. Immunology. 94(3). 297–303. 25 indexed citations

14.

Bermudez, Luiz E., Mary Petrofsky, Martin Wu, & Lowell S. Young. (1998). Clarithromycin Significantly Improves Interleukin‐12‐Mediated Anti‐Mycobacterium aviumActivity and Abolishes Toxicity in Mice. The Journal of Infectious Diseases. 178(3). 896–899. 7 indexed citations

15.

Bermudez, Luiz E. & Mary Petrofsky. (1997). Regulation of the expression of Mycobacterium avium complex proteins differs according to the environment within host cells. Immunology and Cell Biology. 75(1). 35–40. 9 indexed citations

16.

Bermudez, Luiz E., et al.. (1996). Effect of Ethambutol on Emergence of Clarithromycin-Resistant Mycobacterium avium Complex in the Beige Mouse Model. The Journal of Infectious Diseases. 174(6). 1218–1222. 27 indexed citations

17.

Bermudez, Luiz E., et al.. (1995). Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice. Journal of Antimicrobial Chemotherapy. 36(4). 641–646. 1 indexed citations

18.

Young, Lawrence S., et al.. (1993). Exposure to Ethanol Up-Regulates the Expression of Mycobacterium avium Complex Proteins Associated with Bacterial Virulence. The Journal of Infectious Diseases. 168(4). 961–968. 26 indexed citations

19.

Bermudez, Luiz E., Mary Petrofsky, Peter Kolonoski, & Lawrence S. Young. (1992). An Animal Model of Mycobacterium avium Complex Disseminated Infection after Colonization of the Intestinal Tract. The Journal of Infectious Diseases. 165(1). 75–79. 95 indexed citations

20.

Bermudez, Luiz E., Martin Wu, Mary Petrofsky, & Lawrence S. Young. (1992). Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infection and Immunity. 60(10). 4245–4252. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact